Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

US Market Report for Neuromodulation Devices 2017 - MedCore

ReportBuyer
Posted on: 17 Nov 16

PR Newswire

LONDON, Nov. 17, 2016

LONDON, Nov. 17, 2016 /PRNewswire/ -- Description
Market growth will be propelled by wider acceptance of neuromodulation products, allowing them to be used on a larger proportion of potential patients. In addition, many neuromodulation patients require multiple devices over their lifetimes because the battery life of neuromodulation devices are limited, ranging from three to ten years. Furthermore, the neuromodulation market had a relatively low penetration rate in 2016 and therefore has excellent growth potential. The GES market will be the slowest growing segment in the neuromodulation device market because the procedure has not gained widespread acceptance and the device only has humanitarian device exemption (HDE) status, limiting its usage to 4,000 units per year. The fastest growing segment is projected to be the DBS market. This market will benefit from the expected entry of new competitors into the market, which will lead to increasing ASP and unit sales through the established sales network of St. Jude Medical and potentially Boston Scientific.

Abstract
Neuromodulation devices are used for regulating the nervous system, either to correct an abnormality in the system or to treat a condition. The devices consist of a pulse generator, leads and electrodes. The electrodes are connected to the desired stimulation area on one end and the pace generator on the other using leads. The pulse generator delivers small pulses of electricity from an internal battery to regulate the activity of the indicated nerve. This report covers the markets for spinal cord stimulators (SCSs), vagus nerve stimulators (VNSs), deep brain stimulators (DBSs), gastric electric stimulators (GESs) and sacral nerve stimulators (SNSs).
Scope:2013-2023
Companies
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Download the full report: https://www.reportbuyer.com/product/4353035/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-market-report-for-neuromodulation-devices-2017---medcore-300365285.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 17/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.